BlackRock Advisors’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

BlackRock Advisors’s Portfolio ASPX Stock Details ASPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-19,642	Closed	-$1.97M	–	3814
2015 Q1	$1.97M	Buy	19,642 +14,347	+271%	+$956K	﹤0.01%	1240
2014 Q4	$278K	Sell	5,295 -7,054	-57%	-$207K	﹤0.01%	2419
2014 Q3	$317K	Buy	12,349 +1,723	+16%	+$36.7K	﹤0.01%	2313
2014 Q2	$237K	Buy	10,626 +8,370	+371%	+$183K	﹤0.01%	2527
2014 Q1	$69K	Buy	+2,256	New	+$60.6K	﹤0.01%	3176

BlackRock Advisors's ASPX Position: Q2 2015 in Review

BlackRock Advisors sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 19,642 shares — an estimated $1.97M sold.

BlackRock Advisors first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $1.97M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

BlackRock Advisors reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
BlackRock Advisors sold 19,642 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $1.97M.
BlackRock Advisors first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
BlackRock Advisors's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $1.97M in Q1 2015.
0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on BlackRock Advisors's 13F filing for Q2 2015, filed 7 Aug 2015.